Evidence map›Paper›PMID 34465395›Full record

ArticleArthritis research & therapy2021

A matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis.

Louie C Alexander, Grant McHorse, Janet L Huebner, Anne-Christine Bay-Jensen, Morten A Karsdal, Virginia B Kraus

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Clinical validation of CAging cell · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Louie C AlexanderDuke Molecular Physiology Institute, Duke University School of Medicine, PO Box 104775, Carmichael Building, 300 N. Duke St, Durham, NC, 27701, USA.
Grant McHorseDuke Molecular Physiology Institute, Duke University School of Medicine, PO Box 104775, Carmichael Building, 300 N. Duke St, Durham, NC, 27701, USA.
Janet L HuebnerDuke Molecular Physiology Institute, Duke University School of Medicine, PO Box 104775, Carmichael Building, 300 N. Duke St, Durham, NC, 27701, USA.
Anne-Christine Bay-JensenImmunoScience, Nordic Bioscience, Herlev, Denmark.
Morten A KarsdalImmunoScience, Nordic Bioscience, Herlev, Denmark.
Virginia B KrausDuke Molecular Physiology Institute, Duke University School of Medicine, PO Box 104775, Carmichael Building, 300 N. Duke St, Durham, NC, 27701, USA. vbk@duke.edu.ORCID 0000-0001-8173-8258
Duke University · USNordic Bioscience (Denmark) · DK

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Sarah B. Peskoe · 2006 to 2026
$24.6M
NIA NIH HHS P30 AG028716NIA NIH HHS P30-AG028716
6 · The paper itself

Abstract

objectiveTo compare C-reactive protein (CRP) and matrix metalloproteinase-generated neoepitope of CRP (CRPM) as biomarkers of inflammation and radiographic severity in patients with knee osteoarthritis.

methodsParticipants with symptomatic osteoarthritis (n=25) of at least one knee underwent knee radiographic imaging and radionuclide etarfolatide imaging to quantify inflammation of the knees and other appendicular joints. For purposes of statistical analysis, semi-quantitative etarfolatide and radiographic imaging scores were summed across the knees; etarfolatide scores were also summed across all joints to provide a multi-joint synovitis measure. Multiple inflammation and collagen-related biomarkers were measured by ELISA including CRP, CRPM, MMP-generated neoepitopes of type I collagen and type III collagen in serum (n=25), and CD163 in serum (n=25) and synovial fluid (n=18).

resultsBMI was associated with CRP (p=0.001), but not CRPM (p=0.753). Adjusting for BMI, CRP was associated with radiographic knee osteophyte score (p=0.002), while CRPM was associated with synovitis of the knee (p=0.017), synovitis of multiple joints (p=0.008), and macrophage marker CD163 in serum (p=0.009) and synovial fluid (p=0.03). CRP correlated with MMP-generated neoepitope of type I collagen in serum (p=0.045), and CRPM correlated with MMP-generated neoepitope of type III collagen in serum (p<0.0001). No biomarkers correlated with age, knee pain, or WOMAC pain.

conclusionsTo our knowledge, this is the first time that CRPM has been shown to be associated with knee and multi-joint inflammation based on objective imaging (etarfolatide) and biomarker (CD163) measures. These results demonstrate the capability of biomarker measurements to reflect complex biological processes and for neoepitope markers to more distinctly reflect acute processes than their precursor proteins. CRPM is a promising biomarker of local and systemic inflammation in knee OA that is associated with cartilage degradation and is independent of BMI. CRPM is a potential molecular biomarker alternative to etarfolatide imaging for quantitative assessment of joint inflammation.

Indexed as

C-Reactive ProteinOsteoarthritis, KneeBiomarkersHumansInflammationKnee JointMatrix MetalloproteinasesBiomarkersC-Reactive ProteinMatrix MetalloproteinasesBiomarkersC-reactive protein (CRP)InflammationOsteoarthritisSynovitis

Identifiers

PMID34465395
PMCPMC8407005
OpenAlexW3198374654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.